The shortest month of the year was not short on large rounds of funding. February picked up right where January left off in getting 2018 off to a strong start. Below are five of the largest rounds of funding secured by NYC-based startups in February of 2018.
PAIGE.AI – $25M
Round: Series A
Industry: Medical, A.I., Machine Learning
Investors: 1 – Breyer Capital
Company: Founded in 2018, PAIGE.AI specializes in designing AI technology to assist with cancer research. PAIGE.AI has partners with the oldest and largest private cancer center in the world — The Memorial Sloan Kettering Cancer Center — in order to bring new tools to the field of pathology research. As a benefit of the partnership, PAIGE.AI will be allowed access to Sloan Kettering’s repository of some 25 million pathology slides. It is hoped that armed with this data, PAIGE.AI’s technology will be able to achieve new insights which lead to breakthrough cancer treatments. This is the first round of funding secured by the company.
Stash – $37.5M
Round: Series D
Industry: Fintech, Personal Finance, Investing
Investors: 6 – Breyer Capital, Coatue Management, Entree Capital, Goodwater Capital, Union Square Ventures, Valar Ventures
Company: Founded in 2015 after a $1.5 million angel investment, Stash has quickly carved-out a place in the fintech space and has gained particular popularity among millennials. The NYC-based startup allows customers to invest as little as $5 and charges no commission fee for buying or selling, or for deposits or withdrawals. Instead, the app charges a nominal monthly fee of $1. To date, Stash has secured five rounds of funding totaling $116.3 million.
Glossier – $52M
Round: Series C
Industry: Fashion, Beauty, Healthcare
Investors: 2 – IVP (Institutional Venture Partners), Index Ventures
Company: Founded in 2014, Glossier is a direct-to-consumer based company providing beauty products to its customers. Selling everything from skin cream to makeup, the company began as a beauty blog run by company founder and CEO, Emily Weiss. By selling high-quality affordable beauty products, the company has developed and engaged a young and fiercely loyal fanbase. To date, Glossier has raised $86.4 million from four rounds of funding.
Kallyope – $66M
Round: Series B
Industry: Biotech, Medicine, Healthcare, Pharmaceutical
Investors: 7 – Alexandria Venture Investments, Euclidean Capital, Illumina Ventures, Lux Capital, Polaris Partners, The Column Group, Two Sigma Ventures
Company: Founded in 2015, Kallyope is a company researching how our gastrointestinal system effects our overall health and wellbeing. Currently, the company is researching the involvement of our GI system in such areas as mood-disorders, anxiety, and even depression. By implementing cutting-edge technology, Kallyope hopes to make progress in this growing field in the physiological and biotechonlogy space. To date, Kallyope has raised $110 million from two rounds of funding.
Harry’s – $112M
Round: Series D
Industry: Lifestyle, Shaving, Grooming
Investors: 2 – Alliance Consumer Growth, Temasek Holdings
Company: Founded in 2011, Harry’s is based on the idea that consumers want ‘a great shave at a fair price’. Made ‘by real guys, for real guys’, Harry’s is a New York City-based company that makes and sells high-quality shave products. By selling direct-to-consumer, Harry’s is able to sell high-quality products at a fraction of competitor’s prices. Harry’s also gives 1% of its sales back to organizations that prepare people for personal and professional success. To date, Harry’s has raised over $474.6 million from nine rounds of funding.